|
|
| Research article summary (published 29 Nov 2003): |
Estimating predictors for long- or short-term survivors.
Full Abstract
Suppose that the response variable in a well-executed clinical or observational study to evaluate a treatment is the time to a certain event, and a set of baseline covariates or predictors was collected for each study patient. Furthermore, suppose that a significant number of study patients had nontrivial, long-term adverse effects from the treatment. A commonly posed question is how to use these covariates from the study to identify future patients who would (or would not) benefit from the treatment. In this article, we present "point" and "interval" estimates for the set of covariate or predictor vectors associated with a specific patient survival status, e.g., long- (or short-) term survival, in the presence of censoring. These estimates can be easily displayed on a two-dimensional plane, even for the case with high-dimensional covariate vectors. These simple numerical and graphical procedures provide useful information for patient management and/or the design of future studies, which are key issues in pharmacogenomics with genetic markers. The new proposal is illustrated with a data set from a cancer study for treating multiple myeloma.
Author information
Author/s: Tian, L (L); Wang, W (W); Wei, L J (LJ);
Affiliation: Department of Biostatistics, Harvard School of Public Health, 677 Huntington Ave., Boston, Massachusetts 02115, USA. ltian(-atsign-)hsph.harvard.edu
Grants: AI24643 (Agency:NIAID NIH HHS) ; AI52817 (Agency:NIAID NIH HHS)
Journal and publication information
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
Journal: Biometrics (Biometrics), published in United States. (Language: eng)
Reference: 2003-Dec; vol 59 (issue 4) : pp 1008-15
Dates: Created 2004/02/18; Completed 2004/06/29; Revised 2007/11/14;
PMID: 14969480, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis. The Medical Research Council Working Party for Leukaemia in Adults.
23 Jan 1992 - Consolidation hemibody radiotherapy following induction combination chemotherapy in high-tumor-burden multiple myeloma.
30 Oct 1992 - Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma.
30 Aug 1992 - [Plasma cell leukemia. Study of 6 patients]
30 Jul 1992 - Modified adriamycin-vincristine-dexamethasone (m-VAD) in primary refractory and relapsed plasma cell myeloma: an NCI (Canada) pilot study. The National Cancer Institute of Canada Clinical Trials Group.
30 Oct 1992 - Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support.
29 Sep 1992 - Analysing the temporal effects of age, period and cohort.
30 Dec 1991 - Meta-analysis of chemotherapy in multiple myeloma.
30 Jul 1992 - Relationship between disease-free interval and survival in patients with recurrent melanoma.
30 Oct 1992 - Treatment of melphalan-resistant multiple myeloma with vincristine, BCNU, doxorubicin, and high-dose dexamethasone (VBAD).
30 Dec 1991
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.